What does Dr.Brigitte DE GEYTER Médecine Générale do?

Dr.Brigitte DE GEYTER Médecine Générale is a general practice in Waterloo. Private Limited, started on 19 April 2017, 1 establishment.

What is the address of Dr.Brigitte DE GEYTER Médecine Générale?

The registered office of Dr.Brigitte DE GEYTER Médecine Générale is located at Avenue des Eglantines 13 b, 1410 Waterloo.

Is Dr.Brigitte DE GEYTER Médecine Générale still active?

Yes. According to the CBE (29 September 2026) Dr.Brigitte DE GEYTER Médecine Générale is active, legal situation “Normale toestand”, started on 19 April 2017.

Is Dr.Brigitte DE GEYTER Médecine Générale registered on Peppol?

Yes, Dr.Brigitte DE GEYTER Médecine Générale is registered on the Peppol network with ID 0208:0674645688.

What is the enterprise number of Dr.Brigitte DE GEYTER Médecine Générale?

The enterprise number of Dr.Brigitte DE GEYTER Médecine Générale is BE0674645688.

When was Dr.Brigitte DE GEYTER Médecine Générale founded?

Dr.Brigitte DE GEYTER Médecine Générale was founded on 19 April 2017.

Who are the directors of Dr.Brigitte DE GEYTER Médecine Générale?

According to the 2025 annual accounts, the directors of Dr.Brigitte DE GEYTER Médecine Générale are: Brigitte Renilde De Geyter.

Is Dr.Brigitte DE GEYTER Médecine Générale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 April 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr.Brigitte DE GEYTER Médecine Générale make in 2025?

Dr.Brigitte DE GEYTER Médecine Générale posted a profit after taxes of € 99,463 in financial year 2025.

What is the revenue of Dr.Brigitte DE GEYTER Médecine Générale?

As a small company, Dr.Brigitte DE GEYTER Médecine Générale is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 133,385.

Dr.Brigitte DE GEYTER Médecine Générale (Private Limited)

Dossier Dr.Brigitte DE GEYTER Médecine Générale, printed on 29 September 2026 from databakkes.be/en/0674645688/dr-brigitte-de-geyter-medecine-generale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr.Brigitte DE GEYTER Médecine Générale from Waterloo, company number BE0674645688, closed financial year 2025 with a result of € 99,463 after tax. For that financial year Dr.Brigitte DE GEYTER Médecine Générale recorded a gross margin of € 133,385 and equity of € 5,000. Compared with financial year 2024, the result moved from € 81,287 to € 99,463. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Healthy

€ 5,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,463

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 14,935

▼ 82% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 99,463 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 7,373

▼ 3% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,193 Gross margin 2022: € 64,193 First fiscal year in the series	€ 66,715 Gross margin 2023: € 66,715 ▲ 4% vs 2022 (€ 64,193) Favourable step	€ 109,263 Gross margin 2024: € 109,263 ▲ 64% vs 2023 (€ 66,715) Favourable step	€ 133,385 Gross margin 2025: € 133,385 ▲ 22% vs 2024 (€ 109,263) Favourable step	▲ 22%
Profit after taxes	€ 47,613 Profit after taxes 2022: € 47,613 First fiscal year in the series	€ 49,478 Profit after taxes 2023: € 49,478 ▲ 4% vs 2022 (€ 47,613) Favourable step	€ 81,287 Profit after taxes 2024: € 81,287 ▲ 64% vs 2023 (€ 49,478) Favourable step	€ 99,463 Profit after taxes 2025: € 99,463 ▲ 22% vs 2024 (€ 81,287) Favourable step	▲ 22%
Equity	€ 20,554 Equity 2022: € 20,554 First fiscal year in the series	€ 5,000 Equity 2023: € 5,000 ▼ 76% vs 2022 (€ 20,554) Unfavourable step	€ 5,000 Equity 2024: € 5,000 Unchanged (€ 5,000) Unchanged	€ 5,000 Equity 2025: € 5,000 Unchanged (€ 5,000) Unchanged
Total debts	€ 52,909 Total debts 2022: € 52,909 First fiscal year in the series	€ 69,767 Total debts 2023: € 69,767 ▲ 32% vs 2022 (€ 52,909) Unfavourable step	€ 88,874 Total debts 2024: € 88,874 ▲ 27% vs 2023 (€ 69,767) Unfavourable step	€ 26,839 Total debts 2025: € 26,839 ▼ 70% vs 2024 (€ 88,874) Favourable step	▼ 70%
Cash	€ 59,865 Cash 2022: € 59,865 First fiscal year in the series	€ 63,401 Cash 2023: € 63,401 ▲ 6% vs 2022 (€ 59,865) Favourable step	€ 82,293 Cash 2024: € 82,293 ▲ 30% vs 2023 (€ 63,401) Favourable step	€ 14,935 Cash 2025: € 14,935 ▼ 82% vs 2024 (€ 82,293) Unfavourable step	▼ 82%
Retained profit	€ 1,954 Retained profit 2022: € 1,954 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 1,954) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 47,800 Dividend 2022: € 47,800 First fiscal year in the series	€ 51,432 Dividend 2023: € 51,432 ▲ 8% vs 2022 (€ 47,800) Unchanged	€ 81,287 Dividend 2024: € 81,287 ▲ 58% vs 2023 (€ 51,432) Unchanged	€ 99,463 Dividend 2025: € 99,463 ▲ 22% vs 2024 (€ 81,287) Unchanged	▲ 22%
Balance sheet total	€ 73,463 Balance sheet total 2022: € 73,463 First fiscal year in the series	€ 74,767 Balance sheet total 2023: € 74,767 ▲ 2% vs 2022 (€ 73,463) Unchanged	€ 93,874 Balance sheet total 2024: € 93,874 ▲ 26% vs 2023 (€ 74,767) Unchanged	€ 31,839 Balance sheet total 2025: € 31,839 ▼ 66% vs 2024 (€ 93,874) Unchanged	▼ 66%

Key figures of Dr.Brigitte DE GEYTER Médecine Générale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr.Brigitte DE GEYTER Médecine Générale?

What happened at Dr.Brigitte DE GEYTER Médecine Générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 99,463 (▲ 22% vs 2024). Source: NBB ↗
2023 Brigitte Renilde De Geyter became a director. NBB
Apr 19, 2017 New establishment in Waterloo. KBO
Apr 19, 2017 Start of the company according to the CBE. KBO

In short

From € 47,613 profit in 2022 to € 99,463 profit in 2025.

Paid € 92,703 in corporate taxes since 2022.

Best year ever: 2025, with € 99,463 profit.

Paid out € 279,981 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr.Brigitte DE GEYTER Médecine Générale? We notify you, reason included.

Follow Dr.Brigitte DE GEYTER Médecine Générale

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Brigitte Renilde De Geyter

Dr.Brigitte DE GEYTER Médecine Générale

Behind Dr.Brigitte DE GEYTER Médecine Générale is Brigitte Renilde De Geyter.

See the full network in the app

Directors

According to the 2025 annual accounts

Brigitte Renilde De Geyter

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue des Eglantines 13 b

1410 Waterloo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0674.645.688
VAT number: BE 0674.645.688
Registered office: Avenue des Eglantines 13 b, 1410 Waterloo
Names & denominations: Dr.Brigitte DE GEYTER Médecine Générale · Dr.Brigitte DE GEYTER Algemene Geneeskunde
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 April 2017
Peppol: Active · Active since 15 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗